These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26796403)

  • 21. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
    Siontis GC; Stefanini GG; Mavridis D; Siontis KC; Alfonso F; Pérez-Vizcayno MJ; Byrne RA; Kastrati A; Meier B; Salanti G; Jüni P; Windecker S
    Lancet; 2015 Aug; 386(9994):655-64. PubMed ID: 26334160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis.
    Iofina E; Haager PK; Radke PW; Langenberg R; Blindt R; Ortlepp J; Kühl H; Hanrath P; Hoffmann R
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):28-34. PubMed ID: 15619307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus-eluting stents vs brachytherapy for restenosis.
    Alfonso F; Sabate M
    JAMA; 2006 Oct; 296(15):1837-8; author reply 1838. PubMed ID: 17047209
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.
    Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choice of drug-eluting stents.
    Med Lett Drugs Ther; 2012 Dec; 54(1406):102-3. PubMed ID: 23282791
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
    Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
    Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
    Solinas E; Dangas G; Kirtane AJ; Lansky AJ; Franklin-Bond T; Boland P; Syros G; Kim YH; Gupta A; Mintz G; Fahy M; Collins M; Kodali S; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2008 Aug; 102(3):311-5. PubMed ID: 18638592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
    Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
    Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.
    Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F
    EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
    Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
    J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Coated Balloon Is Less Effective for Treatment of DES In-Stent Restenosis Both in Native Coronary Arteries and Saphenous Vein Grafts: Results From a Bicenter Registry.
    Resch M; Ostheim P; Endemann DH; Debl K; Buchner S; Birner C; Maier LS; Kerber S; Luchner A; Griese DP
    J Interv Cardiol; 2016 Oct; 29(5):461-468. PubMed ID: 27477024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.